Stocks
Ionis Pharmaceuticals (IONS) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 1 284% | 1 303% | 3 592% | 4 144% | 3 212% | 2 764% | |||
| Changes by years, y/y, % | -1 064pp | +19pp | +2 289pp | +553pp | -933pp | +6.5% | |||
Ionis Pharmaceuticals. R&D/CAPEX, %
Ionis Pharmaceuticals. R&D/CAPEX, changes, pp
Ionis Pharmaceuticals (IONS) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 6 634% | 31 325% | 3 738% | 1 096% | 3 540% | 2 764% | ||
| Changes by years, y/y, % | +4 042pp | +25 173pp | +2 050pp | -663pp | -3 094pp | |||
| Changes by quarters, q/q, % | +4 874pp | +24 692pp | -27 587pp | -2 642pp | +2 444pp | |||
